Company / R&D per Share
SUTRO BIOPHARMA, INC. R&D per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$30.34
FY2025
5-year range
$1.43 / $30.34
FY2021-FY2025
Trend
+1249.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +1250% YoY in FY2025, a notable deviation from the 7-year average annual change of +166%.
Based on SEC 10-K filings.
30.34 in FY2025 with a 5-year CAGR of +66.8%.
Improved from $1.82 to $30.34 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +163.4%
- 5-Year CAGR
- +66.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- SUTRO BIOPHARMA, INC.'s r&d per share has grown for 4 consecutive years.
- In FY2025, r&d per share increased 1249.6% year-over-year.
- Peak r&d per share was recorded in FY2018.
- Lowest r&d per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -3.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $30.34 | +1249.6% |
| FY2024 | $2.25 | +23.8% |
| FY2023 | $1.82 | +9.3% |
| FY2022 | $1.66 | +15.8% |
| FY2021 | $1.43 | -39.0% |
| FY2020 | $2.35 | -1.8% |
| FY2019 | $2.39 | -97.4% |
| FY2018 | $93.59 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026